These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effectiveness of antiviral treatment of patients with chronic hepatitis C (a Polish multicenter study)].
    Author: Juszczyk J, Bolewska B, Flieger J, Swietek K, Adamek B, Biskupska-Karasińska M, Dziambor AP, Boroń-Kaczmarska A, Wawrzynowicz-Syczewska M, Cianciara J, Kozłowska J, Daniluk J, Słomka M, Dudziak M, Zaborowski P, Gładysz A, Piszko P, Gonciarz Z, Mazur W, Machniak M, Kryczka W, Zarebska-Michaluk D, Trocha H, Witczak-Malinowska K, Lakomy E, Kuydowicz J, Niwicka-Michałowska A.
    Journal: Pol Merkur Lekarski; 2001 Oct; 11(64):340-3. PubMed ID: 11770315.
    Abstract:
    Interferon alpha (INF) is routine treatment in patients with chronic hepatitis C. Many controlled investigations were evaluated to establish the optimal schedule of treatment with sustained virological and biochemical response. Recently, multicentre meta-analyses suggest that combination therapy (INF + Ribavirin) was more effective than treatment with interferon alone. The aim of this study was to compare the efficacy of four schedules of antiviral treatment in 445 patients with chronic hepatitis C. Combination therapy (INF + Ribavirin) given for 6 mo. and monotherapy (INF) for 18 mo. were more effective than interferon alone given for 6 mo. Treatment with INF alone for 6 mo. was demonstrated to be insufficient.
    [Abstract] [Full Text] [Related] [New Search]